BCL2L11 and acute lymphoblastic leukemia: Here, the TP53 variant in pro-B-ALL SEM and the BCL-6–BIM axis are probably Ento key targets and can explain the Ento sensitivity, therefor providing a rationale for Ento application also in a subset of pro-B-ALL.